Press "Enter" to skip to content

New patent for Eli Lilly drug ADCIRCA


Annual Drug Patent Expirations for ADCIRCA
Annual Drug Patent Expirations for ADCIRCA

Adcirca is a drug marketed by Eli Lilly Co
and is included in one NDA. It is available from three suppliers. There are three patents protecting this drug and one Paragraph IV challenge.

This drug has two hundred and fourteen patent family members in fifty-two countries.

The generic ingredient in ADCIRCA is tadalafil. Three suppliers are listed for this compound. Additional details are available on the tadalafil profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!